When Washington state legalized recreational marijuana, libertarian James Lathrop saw running a dispensary as something of a political duty. Indeed, Lathrop, the owner of Cannabis City, Seattle's first legal pot shop, is known for declaring "free the weed" just before opening his doors on July 8, 2014.

Sincere intentions lead to meaningful industry connections. The cannabis industry serves so many different types of people, it was almost a given that this community would eventually begin to polarize. We are seeing this divide now as more pro-cannabis campaigns ramp up nationwide.

There are some activists who believe that “no regulation is the best regulation,” and likewise there are entrepreneurs who would sacrifice all humanistic elements of this legacy industry in order to turn a profit. Neither are helping the movement, and luckily, both are rare.

Cannabis and music go together naturally, as any enthusiast will tell you.

Over the last week, the market has seen MassRoots, Inc. (MSRT) fall 17% and this weakness has created a great opportunity for investors. The market significantly undervalues MSRT's underlying intellectual property, which the company continues to enhance and develop through strategic partnerships.

When investing in cannabis stocks, investors need to be cautious. Many of these companies offer a product which can be easily replicated by another business. This is not the case for MSRT. The company not only has a first move advantage, but its technology is protected by patents and would be very difficult to replicate.

Taking the Lion's Share in the Fastest Growing Market

This fall The Marijuana Show — the first-ever reality show about Cannabis coined the “Shark Tank for Ganjapreneurs” — debuts its second season.

With 20 contestants, and access to $10 million in investment capital the show has expanded tremendously since kicking off its first season in 2014.

The show shoots in Denver October 9-12. Investors will be pitched business plans including the first cannabis car since the Model T Ford, CBD vodka, and CBD dog bones created by a 10-year-old CEO and his mother.

CANNABIS IS NOT YET MAINSTREAM

When you take a moment to discuss medical cannabis with others, the odds are in your favour that they have tried the product and have an opinion, but by no means is it a typical conversation among strangers. By taking a look at numerous products that are also considered taboo, for various reasons, perhaps we can better understand the methodology for creating a brand in an industry surrounded by secret.

A Close Look at MassRoots Inc (OTCMKTS:MSRT)

 0

TAMPA, Fla., Sep 29, 2015 (BUSINESS WIRE) -- The absence of industry-wide pesticide testing standards leaves the emerging U.S. cannabis industry highly vulnerable to legal and health risks, but Neutra Corp. NTRR, -2.00% is offering a potential solution to the problem.

Expected to Open by End of Fourth Quarter; $10-12 Million Annual Revenue at Full Capacity at Just This Facility; Cutting-Edge Technological Growing of Medical Grade Cannabis

Lately my friend and colleague Kaliko has been attending cannabis events on behalf of The Weed Blog. One thing that he told me he sees more and more at each event is an ever-growing small army of cannabis industry consultants. There are consultants for growing, consultants for dispensaries, and consultants for just about every ancillary niche that there is in the industry. I see the same thing happening on social media, with everyone claiming to be an expert.